← brief for 2026-10-24 · Slowing decline

Renin-Angiotensin System (RAS) Inhibitors in High-Risk Patients With Type 2 Diabetes and Cardio-Renal Risk

Article No results yet Peer reviewed

Key takeaways

This article discusses blood pressure drugs for people with diabetes and kidney risk. It is a review or discussion piece. There are no new results or data from a trial. It summarizes what is known about these drugs.

Who did this work

Ahmed M (Department of Nephrology, King's College Hospital London, Dubai, ARE) · Ahmad A (Department of Endocrinology, Imperial College London Diabetes Centre, Abu Dhabi, ARE) · Naqvi S (Department of Endocrinology, Imperial College London Diabetes Centre, Abu Dhabi, ARE) · Ahmed K (Faculty of Medicine, Pavol Jozef Šafárik University, Košice, SVK) · Ahmed A (Faculty of Medicine, Andrzej Frycz Modrzewski Krakow University, Krakow, POL) · Naqvi Z (Department of Emergency Medicine, University College London Hospitals NHS Foundation Trust, London, GBR)

Source

Article · Europe PMC, CKD · 2026-10-24
https://europepmc.org/article/PMC/PMC13688004